Each tablet of Equagesic, for oral administration, contains 200 mg meprobamate and 325 mg aspirin.
As an adjunct in the short-term treatment of pain accompanied by tension and/or anxiety in patients with musculoskeletal disease. Clinical trials have demonstrated that in these situations relief of pain is somewhat greater than with aspirin alone. Equagesic is not intended for use longer than 10 days.
Media Articles Related to Equagesic (Meprobamate / Aspirin)
Chest pain: New tool helps doctors decide when tests are needed
Source: Cardiovascular / Cardiology News From Medical News Today [2017.02.17]
A two year follow-up on a study involving more than 10,000 people with stable chest pain finds that an online tool can accurately predict which patients are likely to have normal non-invasive tests...
Survey Data Paint Picture of PCMH Docs
Source: MedPage Today Public Health & Policy [2017.02.17]
(MedPage Today) -- More support staff, better access to patients' medical records
Spinal Manipulation for Back and Neck Pain: Does It Work?
Source: Medscape Anesthesiology Headlines [2017.02.15]
For decades, osteopathic physicians and chiropractors, who sought to relieve patients' back and neck pain with spinal manipulation, were accused of being quacks. But mounting evidence supports it.
New Reports Paint Mixed Picture of State Telemedicine Laws
Source: Medscape Business of Medicine Headlines [2017.02.14]
State laws increasingly support telemedicine, but change has been slow; all 50 state Medicaid programs now cover virtual visits.
Medscape Medical News
New clinical guideline issued for treating low back pain
Source: Clinical Trials / Drug Trials News From Medical News Today [2017.02.14]
The American College of Physicians have just issued their clinical practice guideline for the noninvasive treatment of nonradicular low back pain.